Amphista Therapeutics

Amphista Therapeutics is a leading European targeted protein degradation (TPD) company. We have developed several novel mechanisms to remove disease-causing proteins, with the potential to overcome many limitations of current TPD approaches. Our therapies, known as Amphistas, have the potential to deliver transformative medicines for a wide range of diseases.